SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-20-004409
Filing Date
2020-05-04
Accepted
2020-05-04 17:01:26
Documents
5
Period of Report
2020-06-18
Effectiveness Date
2020-05-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT txmd-def14a_061820.htm DEF 14A 844919
2 GRAPHIC txmddef14a061820001.jpg GRAPHIC 8664
3 GRAPHIC txmddef14a-001.gif GRAPHIC 121362
4 GRAPHIC txmddef14-002.gif GRAPHIC 113630
5 GRAPHIC txmddef14a061820002.jpg GRAPHIC 8196
  Complete submission text file 0001387131-20-004409.txt   1193534
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 20845695
SIC: 2834 Pharmaceutical Preparations